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Abstract
Objectives—Organ failure worsens outcome in sepsis. The Sequential Organ Failure Assessment
(SOFA) score numerically quantifies the number and severity of failed organs. We examined the
utility of the SOFA score for assessing outcome of patients with severe sepsis with evidence of
hypoperfusion at the time of emergency department (ED) presentation.
Design—Prospective observational study.
Setting—Urban, tertiary ED with an annual census of >110,000.
Patients—ED patients with severe sepsis with evidence of hypoperfusion. Inclusion criteria:
suspected infection, two or more criteria of systemic inflammation, and either systolic blood pressure
<90 mm Hg after a fluid bolus or lactate >4 mmol/L. Exclusion criteria age <18 years or need for
immediate surgery.
Interventions—SOFA scores were calculated at ED recognition (T0) and 72 hours after intensive
care unit admission (T72). The primary outcome was in-hospital mortality. The area under the
receiver operating characteristic curve was used to evaluate the predictive ability of SOFA scores at
each time point. The relationship between Δ SOFA (change in SOFA from T0 to T72) was examined
for linearity.
Results—A total of 248 subjects aged 57 ± 16 years, 48% men, were enrolled over 2 years. All
patients were treated with a standardized quantitative resuscitation protocol; the in-hospital mortality
rate was 21%. The mean SOFA score at T0 was 7.1 ± 3.6 points and at T72 was 7.4 ± 4.9 points.
The area under the receiver operating characteristic curve of SOFA for predicting in-hospital
mortality at T0 was 0.75 (95% confidence interval 0.68 - 0.83) and at T72 was 0.84 (95% confidence
interval 0.77-0.90). The Δ SOFA was found to have a positive relationship with in-hospital mortality.
Conclusions—The SOFA score provides potentially valuable prognostic information on in-
hospital survival when applied to patients with severe sepsis with evidence of hypoperfusion at the
time of ED presentation.
*See also p. 1807.
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Recent estimates indicate that the rate of severe sepsis hospitalizations doubled during the past
decade, and the age-adjusted population-based mortality is increasing, resulting in at least
215,000 deaths in the United States yearly (1,2). It is estimated that one half of sepsis
hospitalizations originate in the emergency department (ED), underscoring the importance of
developing and evaluating accurate and reliable methods for assessing illness severity and
prognosis to allow for proper allocation of limited hospital resources (3-5) and inclusion in
early interventions (6,7).
There are several outcome prediction models that are currently available for use in clinical
practice. Among them are the Acute Physiology and Chronic Health Evaluation IV Score (8),
the Simplified Acute Physiology Score III (9), the Logistic Organ Dysfunction Score (10), and
the Mortality Probability Model III (11), which were derived and validated on large groups of
intensive care unit (ICU) patients and require historical data or data after ICU admission for
calculation. Previous investigations have shown that most of these scores possess inadequate
predictive abilities when adapted to ED populations (12). The one ED-based scoring system,
the Mortality in Emergency Department Sepsis score, was derived and validated on large
groups of ED patients with suspected infection (13). Although the Mortality in Emergency
Department Sepsis rule has performed reasonably well in the general population of ED patients
with suspected infection (14), it has been reported to be less accurate in patients who are more
severely ill, where prediction is perhaps more important (15). Accordingly, the validation of a
simple scoring system that would remain accurate when applied to patients with severe sepsis
at the time of ED presentation is of high priority for both bedside clinical care and clinical
research trials.
Previous investigators have identified a link between the number of dysfunctional organs and
both short-term and long-term mortality among ED patients with infection (16). The Sequential
Organ Failure Assessment (SOFA) score is a simple and objective score that allows for
calculation of both the number and the severity of organ dysfunction in six organ systems
(respiratory, coagulatory, liver, cardiovascular, renal, and neurologic) (Table 1), and the score
can measure individual or aggregate organ dysfunction (17). The aims of this study were to
determine whether 1) the SOFA score, when applied to a cohort of ED patients with severe
sepsis with evidence of hypoperfusion, would perform with good accuracy for predicting
hospital mortality, and 2) the Δ SOFA, defined as the change in SOFA score for a predefined
time interval, is positively associated with changes in mortality.
MATERIALS AND METHODS
This study was a preplanned secondary analysis of a prospective registry of consecutive ED
patients with severe sepsis with evidence of hypoperfusion treated with an institutional
quantitative resuscitation protocol that is initiated in the ED at the time of recognition of sepsis
(18). This study protocol was reviewed and approved by the institutional review board for the
conduct of human research before enrollment of patients.
Subjects were enrolled from November 2005 through October 2007 in the ED at Carolinas
Medical Center, an 800-bed teaching hospital with 120,000 ED patient visits per year. Explicit
criteria for enrollment included 1) age >17 years; 2) suspected or confirmed infection; 3) two
or more systemic inflammatory response syndrome criteria (19): heart rate >90 beats per
minute, respiratory rate >20 breaths per minute, temperature >38°C or <36°C, white blood cell
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count >12,000 or <4000 cells/mm3 or >10% bands; and 4) systolic blood pressure <90 mm Hg
or mean arterial pressure <65 mm Hg after a isotonic fluid bolus and anticipated need for ICU
care, or a serum lactate concentration ≥4.0 mmol/L and anticipated need for ICU care.
Exclusion criteria included 1) age <18 years; 2) need for immediate surgery; and 3) absolute
contraindication for a chest central venous catheter.
Eligible subjects were identified by board-certified emergency physicians and were treated in
the ED and medical ICU with an institution-approved quantitative resuscitation protocol that
was previously described (20). All data elements required for calculation of the SOFA score
at the time of ED recognition and resuscitation (T0) and 72 hours after ICU admission (T72),
as well as hospital outcomes, were prospectively collected on standardized forms and entered
into a database for later analysis. For T0 scores, only data available in the ED were used for
calculation; and for T72 scores, data available within 12 hours of the 72-hour time point were
used for calculation. To our knowledge, no physician in the ED had any independent knowledge
of the SOFA score. For purposes of this study, we made one modification in the calculation of
the respiratory component of the SOFA score (Table 1). We preferentially used the PaO2 to
FIO2 ratio (PaO2/FIO2) when arterial blood gases were obtained. In cases where the PaO2 was
not available, we used the peripheral arterial oxygen saturation (SaO2) to FIO2 ratio (SaO2/
FIO2). This substitution has been previously validated with high correlation (21). The
definitions of SOFA score variables were otherwise identical to those reported in the original
publication by Vincent et al (17).
Data Analysis
We defined the primary dependent variable for statistical analysis as in-hospital mortality. The
predictive ability of both the T0 and T72 SOFA scores was evaluated using receiver operating
characteristic (ROC) curve analysis generated on standard statistical software (StatsDirect v
2.7.2). The area under the curve (AUC) was used to compare the discriminatory power of the
scoring system or other clinical variables of interest, with an AUC 1.0 considered perfect
discrimination and 0.5 considered equal to chance (22). Odds ratios were calculated to
determine independent predictors of in-hospital mortality by using logistic regression with
bootstrap correction for 95% confidence intervals (CI) (23). Common ED variables known to
predict in-hospital mortality in critically ill patients were entered into the regression analysis
(24,25). The model was limited to contain no more than one dependent variable for every eight
outcomes. Because of colinearity with the SOFA score, we did not input any physiologic data
contained in the SOFA score into the model as a stand-alone variable.
Continuous data are presented as means and SD and were compared using unpaired Student's t
tests or Mann-Whitney U test, as appropriate. Categorical data are presented as percentages
and were compared using chi-square test. We calculated the Δ SOFA, defined as the change
in SOFA score over 72 hours (T0 SOFA - T72 SOFA) and examined the relationship between
the Δ SOFA and in-hospital mortality graphically and using the Armitage chi-square test for
linear trend (26). For all statistical testing, p < 0.05 was considered significant.
Given that this study examined both absolute values and changes in SOFA score at two time
points (T0 and T72), there was the potential for subjects to die, be transferred, or be discharged
from the hospital before the 72-hour time point. To account for these potential dropouts, we
followed the last observation carried forward principle. Thus, for subjects who were not
available for calculation of 72-hour SOFA (due to death, transfer, or discharge), we used the
available data that were most temporally related to the 72-hour time point. To determine the
impact of this strategy on our results, we performed a sensitivity analysis in which we
recalculated the ROC and relationship between the Δ SOFA and in-hospital mortality using
only subjects with complete data at 72 hours.
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A total of 248 patients were included with an overall in-hospital mortality rate of 21% (51/248).
Table 2 summarizes the demographics and initial clinical characteristics of the entire study
population. The average SOFA score at T0 was 7.1 ± 3.6 points and at T72 was 7.4 ± 4.9 points
in the entire population. Nonsurvivors had significantly higher mean (9.8 points) T0 and mean
(11.8 points) T72 SOFA scores when compared with survivors' T0 and T72 (6.5 and 6.2) mean
scores, respectively (Mann-Whitney U test, p < 0.001). The distribution of T0 SOFA scores
and their respective associated in-hospital mortality rates are shown in Figure 1. As can be
seen, the distribution of scores were slightly skewed, because very high values (>17) were not
present in the sample. The in-hospital mortality associated with each individual T0 score, in
general, showed an increase as the total score increased.
Figure 2 graphically depicts the ability of T0 and T72 SOFA scores for predicting mortality
using ROC curve analysis. The T0 SOFA score demonstrated AUC, suggesting fair accuracy
for mortality prediction (AUC, 0.75; 95% CI 0.68-0.83). The T72 SOFA score demonstrated
AUC, suggesting good accuracy for mortality prediction (AUC, 0.84; 95% CI 0.77-0.90).
To compare the predictive ability of T0 SOFA with those of other clinical variables commonly
available in the ED, ROC curves were constructed to determine the ability of these variables
to predict mortality. The T0 SOFA had a higher AUC (0.75) than did any of the other variables
investigated, including lowest ED systolic blood pressure (AUC, 0.62), highest ED temperature
(AUC, 0.60), highest ED respiratory rate (AUC, 0.50), highest ED heart rate (AUC, 0.50),
lowest ED Glasgow Coma score (AUC, 0.62), ED white blood cell count (AUC, 0.52), highest
ED lactate (AUC, 0.65), and age (AUC, 0.61).
Figure 3 shows the relationship between Δ SOFA and in-hospital mortality. A positive
relationship was found between the Δ SOFA over 72 hours and in-hospital mortality (chi-square
for linear trend, p < 0.001). Subjects with a Δ SOFA of ≥2 points had a two-fold higher mortality
rate (42%) than did the entire cohort (21%). Subjects with a Δ SOFA of ≤-2 points had a
mortality rate of less than one-half (9%) of the entire cohort. Any increase in Δ SOFA (score
worsened over 72 hours) was associated with a 35% in-hospital mortality rate, and any decrease
in Δ SOFA (score improved over 72 hours) was associated with 10% in-hospital mortality.
Recognizing the concern of the potential for confounding variables to affect the prognostic
performance of SOFA, we constructed a logistic regression model and calculated the bias-
adjusted odds ratio using the confounders of age, active malignancy, human immunodeficiency
virus/acquired immunodeficiency syndrome, congestive heart failure, and highest lactate. This
model found T0 SOFA to be a statistically significant predictor of in-hospital mortality, and it
had the highest bias-adjusted odds ratio (1.3, 95% CI 1.14-1.41).
Among the initial cohort of 248 subjects, 19 of 51 nonsurvivors (37%) died in the first 72 hours
of hospitalization, and 11 of 197 survivors (6%) were transferred or discharged from the
hospital in the first 72 hours. We conducted a sensitivity analysis using only subjects who had
complete data at 72 hours (n = 218). The T72 SOFA score AUC slightly declined, and the CIs
slightly widened (AUC, 0.79, 95% CI 0.69-0.86). The strong linear relationship between the
Δ SOFA and the in-hospital mortality was unchanged (chi-square for linear trend, p < 0.001).
DISCUSSION
The results of this study suggest that the SOFA score functions with fair to good accuracy for
predicting in-hospital mortality when applied to patients with severe sepsis with evidence of
hypoperfusion at the time of ED presentation. Furthermore, we found that the Δ SOFA over
72 hours has a statistically significant positive relationship to in-hospital mortality. These data
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suggest that use of the SOFA score is an acceptable method for risk stratification and prognosis
of patients with severe sepsis with evidence of hypoperfusion at the time of ED presentation.
Using absolute values or changes over time, the SOFA score appears to be a potentially useful
tool for either the clinician during bedside assessment or for purposes of clinical research trials
of sepsis.
The SOFA score was created by the Working Group on Sepsis-Related Problems of the
European Society of Intensive Care Medicine, with the intent of creating an objective tool to
describe individual and aggregate organ failure (17). The usefulness of the score has been
previously validated in large cohorts of critically ill patients (27,28). The SOFA score has
several desirable characteristics for application in the ED, because it is easy to calculate at the
bedside and includes clinical and laboratory data that are routinely available in the ED. We are
aware of no previous study that has demonstrated the utility of applying the SOFA score in the
ED at the time of recognition and resuscitation of patients with severe sepsis with evidence of
hypoperfusion.
The adaptation of ICU-based scoring systems to application in the ED has been studied in
previous investigations (12,29). These studies have found the predictive abilities of these
scoring systems to be modest at best, and given that these scores are often complex and require
special software to calculate, the utility of applying them in real time in the ED is limited. The
SOFA score is more practical for use in the ED, given that it is easy to calculate at the bedside,
includes only vital sign and laboratory data that are routinely available, and does not require a
definitive final diagnosis of the acute process. These facts, in addition to the equivalent
performance of the SOFA score observed in this study, suggest that it may be preferred more
than other scores for risk stratification and prognosis.
We made one adaptation to the SOFA score, as originally reported by substituting the SaO2/
FIO2 ratio for the PaO2/FIO2 ratio (21). The ability to make this substitution makes the SOFA
score more desirable and generalizable to the ED setting where it may not necessarily be routine
to obtain arterial blood gases, particularly in patients who are not receiving mechanical
ventilation. However, it remains possible that if we had used the PaO2/FIO2 ratio in all subjects,
our results may have been altered.
Previous investigations have reported the usefulness of assessing the change in SOFA during
ICU care to assess outcome (28,30). To our knowledge, this is the first report examining the
Δ SOFA incorporating calculations from the time of ED presentation and identification through
the early phases of ICU care. We found that the Δ SOFA in this study was associated with
positive, direct, and statistically significant changes in the in-hospital mortality. The
importance of this point is the potential utility of such a measurement to be used as a method
for evaluating clinical treatment progress and as a patient-oriented outcome in clinical research
trials incorporating early sepsis interventions.
This report has several limitations to be considered. First, we made an adaptation to the
respiratory component of the SOFA score, as previously described. It is possible that our results
would have been different if this adaptation had not been made. Second, all scores were
calculated post hoc and not applied in real time. If the scores had been calculated and applied
prospectively, they might have performed with different accuracy because of their potential
impact on disposition decisions. Third, the relatively small size of the sample studied might
have resulted in a less precise estimation of the accuracy of the SOFA score. We followed the
principle of last observation carried forward to account for subjects who were not available at
72 hours for calculation of the SOFA score. Although this is an accepted practice in many
clinical trials, we performed a sensitivity analysis to determine the impact of this strategy on
our results. This sensitivity analysis revealed minimal effect on the T72 SOFA ROC curve
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results and no effect of the positive trend analysis for relationship between Δ SOFA and
mortality. Additionally, we studied only a subset of severe sepsis patients, those with
cardiovascular or metabolic evidence of hypoperfusion. Therefore, our results may not be
generalizable to severe sepsis patients with other criteria for organ dysfunction. Finally, the
72-hour time point to evaluate SOFA may not have been the optimal time point, and other time
points (e.g., 6 or 24 hours) may have yielded different results.
CONCLUSIONS
The SOFA score demonstrated fair to good accuracy for predicting in-hospital mortality when
applied to patients with severe sepsis with evidence of hypoperfusion at the time of ED
presentation. The Δ SOFA over 72 hours has a significant positive relationship to in-hospital
mortality. These data suggest that use of the SOFA score is an acceptable method for risk
stratification and prognosis of ED patients with severe sepsis with evidence of hypoperfusion
and that the Δ SOFA score may be a useful measurement to follow in clinical and research
settings.
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Analysis of time zero (T0) Sequential Organ Failure Assessment (SOFA) score. A, Number of
all subjects categorized by their calculated total T0 SOFA score; B, occurrence of in-hospital
mortality according to T0 SOFA score.
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Receiver operating characteristic curves of time zero (T0) and T72 (72 hours after ICU
admission) Sequential Organ Failure Assessment (SOFA) scores for predicting hospital
mortality. Area under the curve (AUC) followed by 95% confidence intervals are shown.
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The relationship between delta Sequential Organ Failure Assessment (Δ SOFA) score and in-
hospital mortality. Δ SOFA calculated by subtracting time 72 SOFA score from time zero
SOFA score.
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Table 1
The Sequential Organ Failure Assessment (SOFA) score
SOFA score 1 2 3 4
Respirationa
PaO2/FIO2 (mm Hg) <400 <300 <220 <100
SaO2/FIO2 221-301 142-220 67-141 <67
Coagulation
Platelets ×103/mm3 <150 <100 <50 <20
Liver
Bilirubin (mg/dL) 1.2-1.9 2.0-5.9 6.0-11.9 >12.0
Cardiovascularb







Glasgow Coma Score 13-14 10-12 6-9 <6
Renal
Creatinine (mg/dL) or urine
output (mL/d)
1.2-1.9 2.0-3.4 3.5-4.9 or <500 >5.0 or <200
MAP, mean arterial pressure; CNS, central nervous system; SaO2, peripheral arterial oxygen saturation.
a
PaO2/FIO2 ratio was used preferentially. If not available, the SaO2/FIO2 ratio was used
b
vasoactive mediations administered for at least 1 hr (dopamine and norepinephrine μmg/kg/min).
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Table 2
Initial patient demographic and clinical characteristics
Variable All (n = 248) Survivor (n = 197) Nonsurvivor (n = 51) Pa
Age (yrs) 57 ± 17.4 56 ± 17.4 62 ± 16.4 0.008
Race (%) 0.53
White 49 54 49
Black 38 39 49
Gender (%) 0.32
male 48 51 41
Female 52 49 59
T0 SOFA score
Respiratory 1.5 ± 1.3 1.3 ± 1.2 2.2 ± 1.5
Coagulation 0.4 ± 0.8 0.4 ± 0.8 0.5 ± 1.0
Liver 0.5 ± 0.8 0.4 ± 0.7 0.6 ± 1.0
Cardiovascular 2.4 ± 1.3 2.2 ± 1.3 3.0 ± 1.3
CNS 0.9 ± 1.3 0.7 ± 1.1 1.5 ± 1.6
Renal 1.5 ± 1.3 1.4 ± 1.2 2.0 ± 1.5
Total 7.1 ± 3.6 6.5 ± 3.3 9.8 ± 3.5 <0.001
T72 SOFA score
Respiratory 1.5 ± 1.5 1.2 ± 1.3 2.7 ± 1.3
Coagulation 0.6 ± 0.9 0.5 ± 0.9 0.8 ± 1.1
Liver 0.5 ± 0.8 0.4 ± 0.7 0.7 ± 1.0
Cardiovascular 2.3 ± 1.4 2.1 ± 1.4 3.3 ± 1.2
CNS 1.2 ± 1.4 0.9 ± 1.2 2.5 ± 1.5
Renal 1.3 ± 1.3 1.1 ± 1.2 1.9 ± 1.5
Total 7.4 ± 4.9 6.2 ± 3.8 11.8 ± 4.1 <0.001
Initial suspected infection site (%)a
Pneumonia 41 40 45
Urinary 29 31 22
Intra-abdominal 21 22 20
Skin/soft tissue 15 15 12
Blood 11 11 10
Other 16 17 12
Lowest SBP (mm Hg) 72 ± 17.2 73 ± 17.8 68 ± 14.1 0.03
Highest RR (beats/min) 119 ± 25.4 119 ± 26.1 120 ± 23 0.81
Highest RR (breaths/min) 30 ± 11.7 30 ± 11.4 30 ± 13.1 0.81
Temperature (F)
Minimum 97 ± 9.3 97 ± 10.2 96 ± 3.9 0.61
Maximum 101 ± 21.3 101 ± 23.7 99 ± 3.5 0.29
CVP (mm Hg)
Minimum 9 ± 14.4 10 ± 14.4 8 ± 14.6 0.55
Maximum 13 ± 6.1 14 ± 6.2 12 ± 5.7 0.24
Scvo2 (%)
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Variable All (n = 248) Survivor (n = 197) Nonsurvivor (n = 51) Pa
Minimum 67 ± 15.8 69 ± 13.1 65 ± 14.3 0.19
Maximum 77 ± 16.5 79 ± 12.0 77 ± 17.9 0.61
Lowest SaO2 (%) 91 ± 10.3 91 ± 11.1 93 ± 6.2 0.04
Lowest GCS 13 ± 6.1 13 ± 3.2 11 ± 4.8 0.002
WBC (cell/mm3) 16 ± 10 13 ± 9.5 17 ± 11.7 0.54
Lactate (mmol/L) 5 ± 11.1 3 ± 3.0 6 ± 4.5 0.003
T0, time zero; T72, time 72 hr after admission; SOFA, sequential organ failure assessment; CNS, central nervous system; SBP, systolic blood pressure;
RR, respiratory rate; CVP, central venous pressure; Scvo2, central venous oxygen saturation; SaO2, peripheral arterial oxygen saturation; GCS, Glasgow
Coma Score; WBC, white blood cell count.
a
p values calculated using unpaired t tests, Mann-Whitney U tests, or chi-square tests where appropriate
b
totals >100% due to more than one potential site of infection. All values presented as means ± SD or percentages.
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